NEW YORK, Sept. 08, 2016 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Envision Healthcare Holdings, Inc. (“Envision Healthcare” or the “Company”) (NYSE:EVHC) in the United States District Court for the District of Colorado on behalf of current stock holders of Envision Healthcare, seeking to pursue remedies under the Securities Exchange Act of 1934 (the “Exchange Act”).
This action stems from a proposed transaction announced on June 15, 2016, pursuant to which Envision Healthcare will be acquired by AmSurg Corp. (“Parent”) through Parent’s wholly-owned subsidiary, New Amethyst Corp. (“Merger Sub,” and together with Parent, “AmSurg”). On June 15, 2016, the Board caused Envision to enter into an agreement and plan of merger (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, AmSurg will acquire all of the outstanding shares of Envision common stock for 0.334 AmSurg shares per Envision share, in a transaction valued at approximately $4.73 billion. The Complaint alleges that the Form S-4 Registration Statement omits material information with respect to the proposed transaction, which renders the Form S-4 Registration Statement false and misleading.
If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.


MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 



